Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
bupropion hydrochloride
|
| gptkbp:administeredBy |
oral
|
| gptkbp:approvedBy |
gptkb:FDA
1997 |
| gptkbp:ATCCode |
N06AX12
|
| gptkbp:availableOn |
gptkb:tablet
|
| gptkbp:brand |
gptkb:bupropion
gptkb:Wellbutrin gptkb:Aplenzin gptkb:Forfivo_XL |
| gptkbp:chemicalClass |
aminoketone
|
| gptkbp:contraindication |
MAOI use
eating disorder seizure disorder |
| gptkbp:developedBy |
GlaxoSmithKline
|
| gptkbp:eliminationHalfLife |
21 hours
|
| gptkbp:excretion |
urine
feces |
| https://www.w3.org/2000/01/rdf-schema#label |
Zyban
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
norepinephrine reuptake inhibitor
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:sideEffect |
nausea
headache insomnia dry mouth |
| gptkbp:usedFor |
gptkb:depression
smoking cessation |
| gptkbp:bfsParent |
gptkb:bupropion
|
| gptkbp:bfsLayer |
6
|